Benjamin Garfield is a Clinical Research Fellow in the Critical Care and Pulmonary Hypetension, Respiratory and Skeletal Muscle and Muscle Gene Expression research groups, National Heart and Lung Institute.
Ben was awarded a Clinical Research Fellowship by the Medical Research Council in 2013 to undertake a PhD at the NHLI and Imperial supervised by Dr. John Wort, Dr. Paul Kemp and Professor Michael Polkey. The research aims to investigate the role of TGF-beta signalling in the development of muscle weakness in pulmonary arterial hypertension.
Ben attended Nottingham Medical School graduating in 2004. He was awarded his MRCP in 2006. He is a respiratory, critical care and general medicine trainee in his 5th year of registrar training with the London Deanery. He has also completed an MSc in Respiratory Medicine at Imperial.
et al., 2017, miR-542 promotes mitochondrial dysfunction and SMAD activity and is raised in ICU Acquired Weakness, American Journal of Respiratory and Critical Care Medicine, Vol:196, ISSN:1073-449X, Pages:1-12
et al., 2015, Growth differentiation factor-15 is associated with muscle mass in chronic obstructive pulmonary disease and promotes muscle wasting in vivo, Journal of Cachexia, Sarcopenia and Muscle, Vol:7, ISSN:2190-6009, Pages:436-448
et al., 2015, Dexamethasone induces apoptosis in pulmonary arterial smooth musclecells, Respiratory Research, Vol:16, ISSN:1465-993X